<DOC>
	<DOCNO>NCT00565890</DOCNO>
	<brief_summary>In order determine efficacy safety thyroxine replacement , randomize clinical trial thyroxine supplementation VLBW infant hypothyroxinemia first month age conduct .</brief_summary>
	<brief_title>Supplemental Thyroxine Treatment Preterm Infants With Hypothyroxinemia</brief_title>
	<detailed_description>A prospective randomized unmask controlled trial conduct . Newborn infant birth weight less 1500g randomized thyroxine treatment un-treatment group .</detailed_description>
	<criteria>Birth weight : le 1500g Gestation : 22 week 0 day ≤ Serum free thyroxine level lower 0.8 ng/dl Serum thyrotropin low 10 μU/ml Age 2 4 week birth Informed consent know thyroid disease mother</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Weeks</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>low birth weight infant</keyword>
	<keyword>hypothyroxinemia</keyword>
	<keyword>outcome</keyword>
</DOC>